Dare Bioscience, Inc. Increase (Decrease) in Accrued Liabilities
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Accrued Liabilities of -$93.72 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-13
- Dare Bioscience, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$80.38K, a 111.55% decline year-over-year.
- Dare Bioscience, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$13.34K.
- Dare Bioscience, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$1.24M, a 190.22% decline year-over-year.
- Dare Bioscience, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$618.17K, a 487.19% decline year-over-year.
- Dare Bioscience, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$2.25M, a 1412.53% decline from fiscal 2024.
- Dare Bioscience, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $171.47K.
- Dare Bioscience, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$8.27M, a 206.63% decline from fiscal 2022.
- Dare Bioscience, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $7.76M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accrued Liabilities 100 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$80.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$93.72K 10-Q · filed 2026-08-13 | -$1.34M derived: sum of 3 quarters · filed 2026-08-13 | -$1.96M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$13.34K 10-Q · filed 2026-05-14 | -$1.26M derived: sum of 2 quarters · filed 2026-05-14 | -$1.88M derived: sum of 3 quarters · filed 2026-05-14 | -$1.18M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$1.86M derived: sum of 2 quarters · filed 2026-03-26 | -$1.17M derived: sum of 3 quarters · filed 2026-08-13 | -$2.25M 10-K · filed 2026-03-26 | ||
| 2025-09-30 | -$618.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $77.79K derived: sum of 2 quarters · filed 2026-08-13 | -$1.01M 10-Q · filed 2025-11-13 | $373.04K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $695.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$388.07K 10-Q · filed 2026-08-13 | $991.21K derived: sum of 3 quarters · filed 2026-08-13 | $1.15M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$1.08M 10-Q · filed 2026-05-14 | $295.25K derived: sum of 2 quarters · filed 2026-05-14 | $454.90K derived: sum of 3 quarters · filed 2026-05-14 | $405.59K derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.54M derived: sum of 2 quarters · filed 2026-03-26 | $1.49M derived: sum of 3 quarters · filed 2026-03-26 | $171.47K 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $159.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $110.34K derived: sum of 2 quarters · filed 2025-11-13 | -$1.21M 10-Q · filed 2025-11-13 | -$3.41M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$49.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.37M 10-Q · filed 2025-08-14 | -$3.57M derived: sum of 3 quarters · filed 2025-08-14 | -$2.94M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$1.32M 10-Q · filed 2025-05-13 | -$3.52M derived: sum of 2 quarters · filed 2025-05-13 | -$2.89M derived: sum of 3 quarters · filed 2025-05-13 | -$4.18M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.57M derived: sum of 2 quarters · filed 2025-03-31 | -$2.86M derived: sum of 3 quarters · filed 2025-03-31 | -$8.27M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $631.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$654.54K derived: sum of 2 quarters · filed 2024-11-14 | -$6.07M 10-Q · filed 2024-11-14 | $689.34K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$6.70M 10-Q · filed 2024-08-12 | $57.47K derived: sum of 3 quarters · filed 2024-08-12 | -$2.15M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | -$5.41M 10-Q · filed 2024-05-14 | $1.34M derived: sum of 2 quarters · filed 2024-05-14 | -$867.16K derived: sum of 3 quarters · filed 2024-05-14 | $1.94M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $6.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $4.55M derived: sum of 2 quarters · filed 2024-03-28 | $7.36M derived: sum of 3 quarters · filed 2024-03-28 | $7.76M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | -$2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $598.47K derived: sum of 2 quarters · filed 2023-11-09 | $1.00M 10-Q · filed 2023-11-09 | $359.59K derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $3.21M 10-Q · filed 2023-08-10 | $2.57M derived: sum of 3 quarters · filed 2023-08-10 | $2.15M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $401.61K 10-Q · filed 2023-05-11 | -$238.89K derived: sum of 2 quarters · filed 2023-05-11 | -$657.04K derived: sum of 3 quarters · filed 2023-05-11 | $1.19M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$640.50K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.06M derived: sum of 2 quarters · filed 2023-03-30 | $791.32K derived: sum of 3 quarters · filed 2023-03-30 | -$45.87K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | -$418.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.43M derived: sum of 2 quarters · filed 2022-11-10 | $594.63K 10-Q · filed 2022-11-10 | $1.50M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.01M 10-Q · filed 2022-08-09 | $1.92M derived: sum of 3 quarters · filed 2022-08-09 | $2.73M derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | -$837.19K 10-Q · filed 2022-05-12 | $68.48K derived: sum of 2 quarters · filed 2022-05-12 | $881.77K derived: sum of 3 quarters · filed 2022-05-12 | $831.90K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $905.67K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.72M derived: sum of 2 quarters · filed 2022-03-31 | $1.67M derived: sum of 3 quarters · filed 2022-03-31 | $1.26M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $813.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $763.42K derived: sum of 2 quarters · filed 2021-11-10 | $355.39K 10-Q · filed 2021-11-10 | $71.78K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | -$49.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$457.90K 10-Q · filed 2021-08-12 | -$741.52K derived: sum of 3 quarters · filed 2021-08-12 | -$546.74K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$408.03K 10-Q · filed 2021-05-13 | -$691.64K derived: sum of 2 quarters · filed 2021-05-13 | -$496.87K derived: sum of 3 quarters · filed 2021-05-13 | $154.11K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | -$283.62K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$88.84K derived: sum of 2 quarters · filed 2021-03-30 | $562.14K derived: sum of 3 quarters · filed 2021-03-30 | $621.62K 10-K · filed 2021-03-30 | ||
| 2019-09-30 | $194.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $845.76K derived: sum of 2 quarters · filed 2020-11-12 | $905.24K 10-Q · filed 2020-11-12 | $602.09K derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $650.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $710.46K 10-Q · filed 2020-08-12 | $407.31K derived: sum of 3 quarters · filed 2020-08-12 | $394.53K derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | $59.48K 10-Q · filed 2020-05-14 | -$243.67K derived: sum of 2 quarters · filed 2020-05-14 | -$256.45K derived: sum of 3 quarters · filed 2020-05-14 | $151.10K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | -$303.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$315.93K derived: sum of 2 quarters · filed 2020-03-27 | $91.62K derived: sum of 3 quarters · filed 2020-03-27 | -$27.08K 10-K · filed 2020-03-27 | ||
| 2018-09-30 | -$12.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $394.77K derived: sum of 2 quarters · filed 2019-11-12 | $276.06K 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $407.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $288.85K 10-Q · filed 2019-08-14 | ||||
| 2018-03-31 | -$118.71K 10-Q · filed 2019-05-14 | |||||
| 2017-12-31 | $534.83K 10-K · filed 2019-04-01 | |||||
| 2017-06-30 | -$3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$4.42M 10-Q · filed 2017-08-14 | -$5.58M derived: sum of 3 quarters · filed 2017-08-14 | -$4.42M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2017-03-31 | -$1.07M 10-Q · filed 2017-05-12 | -$2.23M derived: sum of 2 quarters · filed 2017-06-13 | -$1.07M derived: sum of 3 quarters · filed 2017-06-13 | -$1.62M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-12-31 | -$1.16M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | $4.00K derived: sum of 2 quarters · filed 2017-06-13 | -$544.00K derived: sum of 3 quarters · filed 2017-08-14 | -$1.27M 10-K/A · filed 2017-06-13 | ||
| 2016-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $611.00K derived: sum of 2 quarters · filed 2017-08-14 | -$113.00K 10-Q · filed 2016-11-03 | $1.93M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-06-30 | -$548.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$1.27M 10-Q · filed 2017-08-14 | $775.00K derived: sum of 3 quarters · filed 2017-08-14 | $2.21M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | -$724.00K 10-Q · filed 2017-05-12 | $1.32M derived: sum of 2 quarters · filed 2017-06-13 | $2.75M derived: sum of 3 quarters · filed 2017-06-13 | $3.32M derived: sum of 4 quarters · filed 2017-06-13 | ||
| 2015-12-31 | $2.05M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | $3.48M derived: sum of 2 quarters · filed 2017-06-13 | $4.04M derived: sum of 3 quarters · filed 2017-06-13 | $3.28M 10-K/A · filed 2017-06-13 | ||
| 2015-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $2.00M derived: sum of 2 quarters · filed 2016-11-03 | $1.24M 10-Q · filed 2016-11-03 | $2.86M derived: sum of 4 quarters · filed 2017-06-13 | ||
| 2015-06-30 | $566.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$195.00K 10-Q · filed 2016-08-04 | $1.43M derived: sum of 3 quarters · filed 2017-06-13 | $889.00K derived: sum of 4 quarters · filed 2017-06-13 | ||
| 2015-03-31 | -$761.00K 10-Q · filed 2016-05-02 | $862.00K derived: sum of 2 quarters · filed 2017-06-13 | $323.00K derived: sum of 3 quarters · filed 2017-06-13 | $1.44M derived: sum of 4 quarters · filed 2017-06-13 | ||
| 2014-12-31 | $1.62M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | $1.08M derived: sum of 2 quarters · filed 2017-06-13 | $2.20M derived: sum of 3 quarters · filed 2017-06-13 | $1.42M 10-K/A · filed 2017-06-13 | $1.24M 10-K · filed 2015-03-19 | |
| 2014-09-30 | -$539.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $577.00K derived: sum of 2 quarters · filed 2015-11-16 | -$204.00K 10-Q · filed 2015-11-16 | $494.00K derived: sum of 4 quarters · filed 2016-03-10 | ||
| 2014-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $335.00K 10-Q · filed 2015-08-06 | $1.03M derived: sum of 3 quarters · filed 2016-03-10 | $1.27M derived: sum of 4 quarters · filed 2016-03-10 | ||
| 2014-03-31 | -$781.00K 10-Q · filed 2015-05-06 | -$83.00K derived: sum of 2 quarters · filed 2016-03-10 | $158.00K derived: sum of 3 quarters · filed 2016-03-10 | -$500.00K derived: sum of 4 quarters · filed 2016-03-10 | $1.49M 10-Q · filed 2014-05-27 | |
| 2013-12-31 | $698.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $939.00K derived: sum of 2 quarters · filed 2016-03-10 | $281.00K derived: sum of 3 quarters · filed 2016-03-10 | -$114.00K 10-K · filed 2016-03-10 | -$467.00K 10-K · filed 2015-03-19 | |
| 2013-09-30 | $241.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$417.00K derived: sum of 2 quarters · filed 2014-11-13 | -$812.00K 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | -$658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$1.05M 10-Q · filed 2014-08-12 | ||||
| 2013-03-31 | -$395.00K 10-Q · filed 2014-05-27 | |||||
| 2012-12-31 | $489.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |